701 - 725 of 8587 Results
Title
Year
-
RESTRICTEDTitle: Should Skin Biopsies Be Performed in Patients Suspected of Having Parkinson’s Disease?Journal Name: Parkinson's DiseasePublisher: Hindawi LimitedVol: 2017Issue #:Start Page: 1End Page: 6Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1155/2017/6064974Best OA location URL: http://downloads.hindawi.com/journals/pd/2017/6064974.pdfCitation Count: 7
-
RESTRICTEDTitle: Glycopeptide drugs: A pharmacological dimension between “Small Molecules” and “Biologics”Journal Name: PeptidesPublisher: Elsevier BVVol: 131Issue #:Start Page: 170369End Page: 170369Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.peptides.2020.170369Best OA location URL: http://manuscript.elsevier.com/S0196978120301182/pdf/S0196978120301182.pdfCitation Count: 34
-
RESTRICTEDTitle: Pharmacological chaperoning of nAChRs: A therapeutic target for Parkinson's diseaseJournal Name: Pharmacological ResearchPublisher: Elsevier BVVol: 83Issue #:Start Page: 20End Page: 29Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.phrs.2014.02.005Best OA location URL: https://europepmc.org/articles/pmc6075820?pdf=renderCitation Count: 54
-
RESTRICTEDTitle: Inhibition of mitogen-activated protein kinase and stimulation of Akt kinase signaling pathways: Two approaches with therapeutic potential in the treatment of neurodegenerative diseaseJournal Name: Pharmacology & TherapeuticsPublisher: Elsevier BVVol: 114Issue #: 3Start Page: 261End Page: 277Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.pharmthera.2007.02.002Best OA location URL: https://europepmc.org/articles/pmc1964795?pdf=renderCitation Count: 94
-
RESTRICTEDTitle: α6β2* and α4β2* Nicotinic Acetylcholine Receptors As Drug Targets for Parkinson's DiseaseJournal Name: Pharmacological ReviewsPublisher: American Society for Pharmacology & Experimental Therapeutics (ASPET)Vol: 63Issue #: 4Start Page: 938End Page: 966Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1124/pr.110.003269Best OA location URL: https://europepmc.org/articles/pmc3186078?pdf=renderCitation Count: 171
-
RESTRICTEDTitle: Glutamate Receptor Ion Channels: Structure, Regulation, and FunctionJournal Name: Pharmacological ReviewsPublisher: American Society for Pharmacology & Experimental Therapeutics (ASPET)Vol: 62Issue #: 3Start Page: 405End Page: 496Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1124/pr.109.002451Best OA location URL: https://europepmc.org/articles/pmc2964903?pdf=renderCitation Count: 2923
-
RESTRICTEDTitle: PARkinson's: From cellular mechanisms to potential therapeuticsJournal Name: Pharmacology & TherapeuticsPublisher: Elsevier BVVol: 230Issue #:Start Page: 107968End Page: 107968Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.pharmthera.2021.107968Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821123Citation Count: 4
-
RESTRICTEDTitle: Human embryonic stem cells for brain repair?Journal Name: Philosophical Transactions of the Royal Society B: Biological SciencesPublisher: The Royal SocietyVol: 363Issue #: 1489Start Page: 87End Page: 99Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1098/rstb.2006.2014Best OA location URL: https://europepmc.org/articles/pmc2605488?pdf=renderCitation Count: 34
-
RESTRICTEDTitle: The Retina in Multiple System Atrophy: Systematic Review and Meta-AnalysisJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 8Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2017.00206Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2017.00206/pdfCitation Count: 32
-
RESTRICTEDTitle: Pharmacogenetics of Antipsychotic-Induced Movement Disorders as a Resource for Better Understanding Parkinson’s Disease Modifier GenesJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 6Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2015.00027Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2015.00027/pdfCitation Count: 7
- Expanding the Repertoire of Biomarkers for Alzheimer’s Disease: Targeted and Non-targeted Approaches2015RESTRICTEDTitle: Expanding the Repertoire of Biomarkers for Alzheimer’s Disease: Targeted and Non-targeted ApproachesJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 6Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2015.00256Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2015.00256/pdfCitation Count: 15
-
RESTRICTEDTitle: Presynaptic Mechanisms of l-DOPA-Induced Dyskinesia: The Findings, the Debate, and the Therapeutic ImplicationsJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 5Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2014.00242Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2014.00242/pdfCitation Count: 177
-
RESTRICTEDTitle: Transcranial static magnetic stimulation —From bench to bedside and beyond—Journal Name: Neuroscience ResearchPublisher: Elsevier BVVol: 156Issue #:Start Page: 250End Page: 255Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neures.2019.12.005Citation Count: 14
-
RESTRICTEDTitle: Disease modifying therapies for Parkinson's disease: Novel targetsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 201Issue #:Start Page: 108839End Page: 108839Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2021.108839Citation Count: 4
-
RESTRICTEDTitle: New dopaminergic therapies for PD motor complicationsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 204Issue #:Start Page: 108869End Page: 108869Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2021.108869Citation Count: 8
-
RESTRICTEDTitle: Etiology, pathological characteristics, and clinical management of black pleural effusionJournal Name: MedicinePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 101Issue #: 8Start Page: e28130End Page: e28130Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1097/md.0000000000028130Best OA location URL: https://doi.org/10.1097/md.0000000000028130Citation Count: 6
-
RESTRICTEDTitle: Impulse control disorders and related behaviors in Parkinson's disease: risk factors, clinical and genetic aspects, and managementJournal Name: Current Opinion in NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 34Issue #: 4Start Page: 547End Page: 555Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/wco.0000000000000955Best OA location URL: https://hal.archives-ouvertes.fr/hal-03298526/file/Manuscript.pdfCitation Count: 13
-
RESTRICTEDTitle: The genetics of Parkinson diseaseJournal Name: Ageing Research ReviewsPublisher: Elsevier BVVol: 42Issue #:Start Page: 72End Page: 85Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.arr.2017.12.007Citation Count: 386
- Sixty‐hertz stimulation improves bradykinesia and amplifies subthalamic low‐frequency oscillations2016RESTRICTEDTitle: Sixty‐hertz stimulation improves bradykinesia and amplifies subthalamic low‐frequency oscillationsJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 1Start Page: 80End Page: 88Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26837Citation Count: 63
-
RESTRICTEDTitle: Targeting of the unfolded protein response (UPR) as therapy for Parkinson's diseaseJournal Name: Biology of the CellPublisher: WileyVol: 111Issue #: 6Start Page: 161End Page: 168Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/boc.201800068Citation Count: 36
-
RESTRICTEDTitle: Living in Promiscuity: The Multiple Partners of Alpha-Synuclein at the Synapse in Physiology and PathologyJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 20Issue #: 1Start Page: 141End Page: 141Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms20010141Best OA location URL: https://www.mdpi.com/1422-0067/20/1/141/pdf?version=1546425034Citation Count: 55
-
RESTRICTEDTitle: Resting-state fMRI in Parkinson's disease patients with cognitive impairment: A meta-analysisJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 62Issue #:Start Page: 16End Page: 27Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.12.016Best OA location URL: https://cris.maastrichtuniversity.nl/files/76214281/Leentjens_2019_Resting_state_fMRI_in_Parkinsons.pdfCitation Count: 129
-
RESTRICTEDTitle: Public Engagement and Neurology: An UpdateJournal Name: Brain SciencesPublisher: MDPI AGVol: 11Issue #: 4Start Page: 429End Page: 429Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/brainsci11040429Best OA location URL: https://www.mdpi.com/2076-3425/11/4/429/pdf?version=1617937511Citation Count: 5
-
RESTRICTEDTitle: Exosomes in Alpha-Synucleinopathies: Propagators of Pathology or Potential Candidates for Nanotherapeutics?Journal Name: BiomoleculesPublisher: MDPI AGVol: 12Issue #: 7Start Page: 957End Page: 957Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/biom12070957Best OA location URL: https://www.mdpi.com/2218-273X/12/7/957/pdf?version=1657271910Citation Count: 14
- Lipotoxicity Downstream of α-Synuclein Imbalance: A Relevant Pathomechanism in Synucleinopathies?2021RESTRICTEDTitle: Lipotoxicity Downstream of α-Synuclein Imbalance: A Relevant Pathomechanism in Synucleinopathies?Journal Name: BiomoleculesPublisher: MDPI AGVol: 12Issue #: 1Start Page: 40End Page: 40Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/biom12010040Best OA location URL: https://www.mdpi.com/2218-273X/12/1/40/pdf?version=1640831739Citation Count: 4